|
Market Closed -
Bombay S.E.
14:02:28 04/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,015.00 INR | +0.15% |
|
+2.86% | -4.59% |
| 09:06am | Lupin Launches Generic HIV Drug in U.S. After FDA Approval | MT |
| 11-04 | Lupin Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
Chart: Technical Analysis
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| LUPIN | Delayed | |
NSE India S.E.
| LUPIN | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2,035 | 2,144.7 | 2,144.7 |
| Spread/Res. | -0.98% | -6.05% | -6.05% |
| Spread/Supp. | +4.68% | +4.68% | +4.68% |
| Support | 1,925 | 1,925 | 1,925 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LUPIN Stock
- Charts Lupin Limited
Select your edition
All financial news and data tailored to specific country editions
